Description
Sexually transmitted diseases (STDs) are a major public health issue. There occur approximately 550 million new STDs annually worldwide. In the US, there are more than 35 million each year. Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics) analyzes the current and potential world market from 2018 to 2023 for tests and systems used to diagnose STDs. The key STDs and diagnostics covered in the report are the following:
- Chlamydia
- Gonorrhea
- Syphilis
- Human Papillomavirus (HPV)
- Human immunodeficiency viruses (HIV)
- Herpes simplex virus (HSV)
- Trichomonas vaginalis (TV)
Geographic Analysis
STD government initiatives worldwide along with advances in healthcare infrastructure are projected to provide a basis for STD market growth. The market for STD diagnostic systems and tests is being driven by efforts worldwide that aim to screen, diagnose, and treat STD infections. To improve the STD landscape, healthcare systems globally have initiated national screening and also incentivized voluntary screening. The report provides geographic analysis of the full STD diagnostics market, including:
- World Market for STD Diagnostics, 2018-2023 ($ billions)
- World Market for STD Diagnostics by Geography, 2018-2023 (NA, Europe-Africa, APAC, South America, ROW)
- World Market for STD Diagnostics by Geography, 2018 (NA, Europe-Africa, APAC, South America, ROW)
- North American Market for STD Diagnostics by Geography, 2018-2023 (US, Canada, Mexico, Total)
- North American Market for STD Diagnostics by Geography (US, Canada, Mexico)
- European-African Market for STD Diagnostics by Geography, 2018-2023 (UK, Spain, France, Italy, Germany, Africa, Total)
- Asian-Pacific (APAC) Market for STD Diagnostics by Geography, 2018-2023 (Japan, China, India, Australia, RO APAC, Total)
- South American Market for STD Diagnostics by Geography, 2018-2023 (Argentina, Brazil, Chile, RO SA, Total)
- Rest of World Market for STD Diagnostics, 2018-2023
Market Analysis by Disease and Region
Sexually Transmitted Disease (STD) Testing Markets examines the diagnostics market for different STDs based on key individual country and regional markets. An increasing number of cases necessitate more complete reporting in developed as well as developing economies. Potential market opportunities lie in improved screening and better awareness, although the stigma of the infection may make people hesitant to be tested and may slightly impede market growth. Market analysis provided includes:
- North American Market for STD Diagnostics, 2018-2023 (Chlamydia, Gonorrhea, Syphilis, Trichomoniasis, HIV, HPV, HSV, Total) ($ billions)
- European-African Market for STD Diagnostics, 2018-2023 (Chlamydia, Gonorrhea, Syphilis, Trichomoniasis, HIV, HPV, HSV, Total)
- Asia-Pacific (APAC) Market for STD Diagnostics, 2018-2023 (Chlamydia, Gonorrhea, Syphilis, Trichomoniasis, HIV, HPV, HSV, Total)
- South American Market for STD Diagnostics, 2018-2023 (Chlamydia, Gonorrhea, Syphilis, Trichomoniasis, HIV, HPV, HSV, Total)
- Rest of World Market for STD Diagnostics, 2018-2023 (Chlamydia, Gonorrhea, Syphilis, Trichomoniasis, HIV, HPV, HSV, Total)
Market Analysis by Testing Location and by Laboratory Type
Laboratory-based testing for STDs currently holds a greater share of the STD diagnostics market. Commercialized POC STD diagnostic technologies are in their early stages and continue to evolve into the marketplace. The report provides market analysis by testing location, including:
- Worldwide Market for STD Diagnostics by Testing Location, 2018-2023 (Laboratory, POC, Total) ($ billions)
- North American Market for STD Diagnostics by Testing Location, 2018-2023 (Laboratory, POC, Total)
- European-African Market for STD Diagnostics by Testing Location, 2018-2023 (Laboratory, POC, Total)
- Asia-Pacific (APAC) Market for STD Diagnostics by Testing Location, 2018-2023 (Laboratory, POC, Total)
- South American Market for STD Diagnostics by Testing Location, 2018-2023 (Laboratory, POC, Total)
- Rest of World Market for STD Diagnostics by Testing Location, 2018-2023 (Laboratory, POC, Total)
The report also illustrates STD laboratory segmentation, including:
- Worldwide Market for STD Diagnostics by Laboratory Type, 2018-2023 (Hospital Lab, Independent Lab, Physician Office Lab, Total) ($ billions)
- North American Market for STD Diagnostics by Laboratory Type, 2018-2023 (Hospital Lab, Independent Lab, Physician Office Lab, Total)
- European-African Market for STD Diagnostics by Laboratory Type, 2018-2023 (Hospital Lab, Independent Lab, Physician Office Lab, Total)
- Asia-Pacific (APAC) Market for STD Diagnostics by Laboratory Type, 2018-2023 (Hospital Lab, Independent Lab, Physician Office Lab, Total)
- South American Market for STD Diagnostics by Laboratory Type, 2018-2023 (Hospital Lab, Independent Lab, Physician Office Lab, Total)
- Rest of World Market for STD Diagnostics by Laboratory Type, 2018-2023 (Hospital Lab, Independent Lab, Physician Office Lab, Total)
Market Analysis by Testing Device
There are several possible STD diagnostic methods in the laboratory, including molecular platforms, lateral flow assays, flow cytometry, and ELISA diagnostics. Lateral flow immunoassays are among the more simple and successful rapid diagnostics, technical advances having resulted in the one-step lateral flow test chemistry often used today. The transition to molecular techniques has optimized the validity of procedures and has sped the time to receiving test results. Flow cytometry – a laboratory technique which measures and analyzes several physical characteristics of cells as they move in a stream under a light beam – should increase thanks to the accuracy of the technology. Technological advancements in ELISA test kits for STD detection are expected to foster growth in this segment as well. The report provides the current market and forecasts for each of these methods:
- World Market for Molecular STD Diagnostics, 2018-2023 ($ billions)
- Worldwide Market for Molecular STD Diagnostics by Geography, 2018-2023 (NA, Europe-Africa, APAC, South America, ROW, Total)
- World Market for Lateral Flow Assay STD Diagnostics, 2018-2023 ($ billions)
- Worldwide Market for Lateral Flow Assay STD Diagnostics by Geography, 2018-2023 (NA, Europe-Africa, APAC, South America, ROW, Total)
- World Market for Flow Cytometry STD Diagnostics, 2018-2023 ($ billions)
- Worldwide Market for Flow Cytometry STD Diagnostics by Geography, 2018-2023 (NA, Europe-Africa, APAC, South America, ROW, Total)
- World Market for ELISA STD Diagnostics, 2018-2023 ($ billions)
- Worldwide Market for ELISA STD Diagnostics by Geography, 2018-2023 (NA, Europe-Africa, APAC, South America, ROW, Total)
- Global Sexually Transmitted Disease (STD) IVD Test Kit and Reagent Market by Test Type & Condition 2018 – 2026 ($millions) (By Type of Test: Immunoassay, Molecular, Other; By Condition: Chlamydia, HPV, Gonorrhea, Herpes HSV-2, Syphilis, Other; Global STD IVD Market; HIV)
Market Trends and Developments
An examination of developing STD trends can reveal opportunities for manufacturers of STD diagnostic tests and systems. Market issues discussed in the report include:
- Incidence, Prevalence, and Cost of STDs
- Antibiotic Resistance
- Non-Reportable STDs
- Emerging STDs
- Newborn Syphilis Cases
- STDs in Women and Infants
- European vs. US Rates
- Highly Susceptible Groups
- Novel Antibiotics Targets Gonorrhea
- At-Home HPV Testing
- First Test to Aid in Diagnosis of Mycoplasma genitalium
- Funding POC Test Development
Competitive Landscape
The growth in the prevalence of STDs has helped spur the market for STD testing that is benefitting the global STD testing manufacturers. Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics) provides profiles of key players in the market, including:
- Alere-Abbott
- Atlas Genetics Ltd. – binx Health
- Beckman Coulter-Danaher
- Becton Dickinson
- Biomeme
- bioMérieux
- Cepheid-Danaher
- GenePOC
- Hologic
- Meridian Bioscience
- OraSure Technologies
- QIAGEN
- QuantuMDx
- Quidel
- Roche Diagnostics
- Seegene
- Sekisui Diagnostics
- Siemens Healthineers
- Trinity Biotech Plc
- uBiome
